Tags |
|
|
Links |
|
|
Digg It - Google Goes Government
Google Inc has teamed up with several states in an effort to make public records more acc
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
essible. On the roster are California, Utah, Virginia and Arizona. Google will help these
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
states remove certain barriers that previously prevented search engines from accessing p
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ublic records such as: education, real estate, health care and environmental records. Goo
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
gle will not have sole access to this information and other major search engines will hav
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
an opportunity to utilize this resource.
Many social privacy advocates have expressed g
Many social privacy advocates have expressed g
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
reat concern for this move as it may have unintended consequences. Many of the records co
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ntain confidential or personal information like social security numbers. However Google m
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
aintains that privacy will be of great concern and there is a high likelihood that confid
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ential information will be redacted both online and on real documents.
Until now users h
Until now users h
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ve had difficulty accessing the specific records they were searching for because governme
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
nt websites are not properly constructed to allow search engine bots to crawl the informa
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
tion on their websites.
According to Aaron Wall of cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
According to Aaron Wall of cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ves/002192.shtml" target="_blank">Seobook this action is likely to increase competiti
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
on in each field of newly available data. “As more of this content comes online,
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
industries such as real estate and insurance will get uglier as commercial players are fo
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
rced out of the SERP and into buying AdWords. But on the upside, if you gain editorial ac
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
cess to one of these trusted websites it should be quite easy to rank for virtually anyth
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/74904/diggit-Google-Goes-Government.html">Google Goes Government</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/74904/diggit-Google-Goes-Government.html]Google Goes Government[/url]
Related Articles:
Corporate America vs. Work/Life Balance
Get Your Performance Appraisal Discussions Off to a Good Start (Part 1)
Electronics Contract Manufacturing Lead Time Reporting
Bookmark it:
|